6949-82-2 Usage
Description
(Z)-3-[[(4-bromophenyl)amino]carbamoyl]prop-2-enoic acid, also known as bromfenac, is a nonsteroidal anti-inflammatory drug (NSAID) characterized by its ability to alleviate pain and reduce inflammation. It is a derivative of phenylacetic acid with a bromine atom attached to the phenyl ring, which contributes to its pharmacological properties. Bromfenac exerts its effects by inhibiting the production of prostaglandins, chemicals responsible for pain and inflammation within the body.
Uses
Used in Pharmaceutical Industry:
Bromfenac is used as an anti-inflammatory agent for the treatment of conditions such as rheumatoid arthritis and osteoarthritis. Its application in this context is due to its ability to reduce the production of prostaglandins, which are involved in the inflammatory process and the sensation of pain.
Used in Ophthalmology:
In the field of ophthalmology, bromfenac is utilized as an anti-inflammatory agent in the form of eye drops. It is specifically prescribed for the treatment of postoperative inflammation and pain following cataract surgery. The localized application of bromfenac directly to the eye allows for targeted relief of inflammation and discomfort associated with the surgical procedure.
Check Digit Verification of cas no
The CAS Registry Mumber 6949-82-2 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,9,4 and 9 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 6949-82:
(6*6)+(5*9)+(4*4)+(3*9)+(2*8)+(1*2)=142
142 % 10 = 2
So 6949-82-2 is a valid CAS Registry Number.
InChI:InChI=1/C10H9BrN2O3/c11-7-1-3-8(4-2-7)12-13-9(14)5-6-10(15)16/h1-6,12H,(H,13,14)(H,15,16)/b6-5-
6949-82-2Relevant articles and documents
A new synthetic route to authentic N-substituted aminomaleimides
Conley,Hung,Willson
, p. 4553 - 4555 (2005)
A number of compounds reported in the literature as N-aminomaleimides (2) are, instead, isomeric N-aminoisomaleimides (3). The ubiquity of this mischaracterization and its propagation within the literature are discussed. In addition, the first general synthetic route to aliphatic and aromatic N-substituted aminomaleimides is described. As an illustration, the compound reported to be N-(4-bromophenylamino)maleimide (2b) was prepared and determined to be N-(4-bromophenylamino)isomaleimide (3b). The authentic compound was synthesized by the condensation of 4-bromophenylhydrazine (7b) and the exo-furan/maleic anhydride Diels-Alder adduct (8) in acetic acid to produce the furan-protected aminomaleimide 10b, followed by heating to remove furan through the retro Diels-Alder reaction. The structures of 2b, 3b, and 10b were established unequivocally by X-ray crystallography and other spectroscopic techniques.